Markus Graefen

Universität Hamburg — Germany

Medicine · Health Sciences

118h-index80.2kcitations1.8kworks2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(1062), Prostate Cancer Treatment and Research(1056), Bladder and Urothelial Cancer Treatments(249), Urologic and reproductive health conditions(200), Cancer, Lipids, and Metabolism(122)

Publications1.7k total

Re: Rebecca Voelker. What Is Prostate Cancer? JAMA. In press. https://doi.org/10.1001/jama.2025.10177
European Urology·2025
Retzius-Sparing-Prostatektomie
Uro-News·2025
Shaping the Future of Positive Surgical Margins During Radical Prostatectomy: Are New Technologies Here To Stay?
European Urology·2025
Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes
World Journal of Urology·2025· 1 citedOpen Access
Sarcomatoid dedifferentiation as a predictor of overall mortality in surgically treated metastatic renal cell carcinoma
Surgical Oncology·2025
USPSTF Recommendation Against PSA Screening vs. Stage and Cancer‐Specific Mortality in Localized Prostate Cancer
The Prostate·2025
Inflammatory bowel disease vs. adverse in-hospital outcomes after radical prostatectomy
Urologic Oncology Seminars and Original Investigations·2025
Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model
Prostate Cancer and Prostatic Diseases·2025· 1 citedOpen Access
Supplementary Table S1 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Table S4 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Data from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Figure S1 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Figure S5 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Figure S4 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Methods S2 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Methods S1 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Figure S3 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Table S2 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Figure S2 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Table S3 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
page 1 of 87Next →

Frequent Co-authors

Hartwig Huland(23), Francesco Montorsi(16), Thorsten Schlomm(16), Thomas Steuber(13), James A. Eastham(11), Guido Sauter(10), Alexander Haese(10), Shahrokh F. Shariat(8), Hans Heinzer(8), Andreas Erbersdobler(8), Ronald Simon(8), Sarah Minner(8), Alberto Briganti(7), Jochen Walz(7), Georg Salomon(7), Giorgio Guazzoni(6), Hendrik Van Poppel(6), Paul Perrotte(6), Pierre I. Karakiewicz(6), Pierre I. Karakiewicz(6)